XML 103 R92.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment reporting information        
Revenues $ 2,681 $ 2,510 $ 7,470 $ 7,066
Selling, general and administrative 795 850 2,556 2,476
Research and development 166 146 468 453
Operating income 619 318 1,339 988
Amortization of intangible assets (253) (274) (765) (818)
Asset impairments (1) 0 (1) (6)
Restructuring, integration and separation costs (17) (1) (49) (25)
Other expense, net (80) (225) (77) (245)
Interest income 15 7 39 24
Interest expense (412) (346) (1,207) (1,051)
Gain on extinguishment of debt 3 0 181 23
Foreign exchange and other (7) 0 (41) (26)
Income (loss) before income taxes 218 (21) 311 (42)
Product sales        
Segment reporting information        
Revenues 2,657 2,482 7,388 6,990
Cost of goods sold and Cost of other revenues 735 682 2,166 2,018
Other revenues        
Segment reporting information        
Revenues 24 28 82 76
Cost of goods sold and Cost of other revenues 15 14 49 37
Operating Segment        
Segment reporting information        
Revenues 2,681 2,510 7,470 7,066
Operating income 1,213 1,066 3,003 2,828
Operating Segment | Salix        
Segment reporting information        
Revenues 716 642 1,885 1,699
Selling, general and administrative 79 147 302 351
Research and development 21 19 59 76
Operating income 570 436 1,396 1,142
Operating Segment | Salix | Product sales        
Segment reporting information        
Cost of goods sold and Cost of other revenues 46 40 128 130
Operating Segment | Salix | Other revenues        
Segment reporting information        
Cost of goods sold and Cost of other revenues 0 0 0 0
Operating Segment | International        
Segment reporting information        
Revenues 286 291 826 832
Selling, general and administrative 57 54 172 164
Research and development 7 5 19 17
Operating income 90 105 253 278
Operating Segment | International | Product sales        
Segment reporting information        
Cost of goods sold and Cost of other revenues 118 113 337 338
Operating Segment | International | Other revenues        
Segment reporting information        
Cost of goods sold and Cost of other revenues 14 14 45 35
Operating Segment | Solta Medical        
Segment reporting information        
Revenues 140 112 381 302
Selling, general and administrative 31 26 91 77
Research and development 9 5 20 12
Operating income 70 53 177 140
Operating Segment | Solta Medical | Product sales        
Segment reporting information        
Cost of goods sold and Cost of other revenues 30 28 93 73
Operating Segment | Solta Medical | Other revenues        
Segment reporting information        
Cost of goods sold and Cost of other revenues 0 0 0 0
Operating Segment | Diversified        
Segment reporting information        
Revenues 258 269 682 722
Selling, general and administrative 41 40 129 134
Research and development 3 3 10 11
Operating income 182 189 448 469
Operating Segment | Diversified | Product sales        
Segment reporting information        
Cost of goods sold and Cost of other revenues 32 37 95 108
Operating Segment | Diversified | Other revenues        
Segment reporting information        
Cost of goods sold and Cost of other revenues 0 0 0 0
Operating Segment | Bausch + Lomb        
Segment reporting information        
Revenues 1,281 1,196 3,696 3,511
Selling, general and administrative 429 420 1,346 1,254
Research and development 41 29 104 87
Operating income 301 283 729 799
Operating Segment | Bausch + Lomb | Product sales        
Segment reporting information        
Cost of goods sold and Cost of other revenues 509 464 1,513 1,369
Operating Segment | Bausch + Lomb | Other revenues        
Segment reporting information        
Cost of goods sold and Cost of other revenues 1 0 4 2
Corporate        
Segment reporting information        
Operating income $ (243) $ (248) $ (772) $ (746)